The Phase 1 Resilient Europe study report feeding into the ex-post evaluation of Horizon 2020 has been published
Since December 2021, PPMI has been leading a two-year evaluation study titled Resilient Europe. Earlier this month, the European Commission published the final Phase 1 study report. The report covers the Horizon 2020 programme from its start in 2014 until the end of 2020. Under this study, the term ‘Resilient Europe’ is understood as encompassing activities that contribute to building a more resilient Europe in terms of addressing the following challenges:
- Societal Challenge 1 – Health, Demographic Change and Wellbeing;
- Societal Challenge 6 – Europe in a changing world – inclusive, innovative and reflective societies;
- Societal Challenge 7 – Secure societies – protecting freedom and security of Europe and its citizens.
Additionally, the following four partnerships are covered under the study:
- Active and Assisted Living Research and Development Programme (AAL2),
- The Second European and Developing Countries Clinical Trials Partnership Programme (EDCTP2),
- Innovative Medicines Initiatives 2 Joint Undertaking (IMI2)
- The European Institute of Innovation & Technology Health (EIT Health).
This study assesses whether interventions and actions linked to Horizon 2020 were relevant, coherent, efficient, generated EU added value, and whether Horizon 2020 worked as expected in achieving its objectives. This supporting study covers the rationale, implementation and achievements, and the longer-term impacts and sustainability of the measures.
The study report was completed by a consortium consisting of PPMI, Prognos, VTT and Maastricht University.
The full report can be found HERE.
This year, PPMI and the partners continue the project working on Phase 2, which will feed into the interim evaluation of Horizon Europe due in 2024.
